Assessing Glycosylated Hemoglobin Thresholds for Development of Cardiovascular Disease by Racial and Ethnic Groups

• Published in: Journal of the American Heart Association Vol. 13; no. 10; p. e033559
• Main Authors: Low, Christopher G, Merchant, Maqdooda, Hung, Yun-Yi, Liu, Yu Hsin, Vu, Joseph, Pursnani, Seema
• Format: Journal Article
• Language: English
• Published: England John Wiley and Sons Inc 21.05.2024; Wiley
• Subjects: Adult; Aged; Biomarkers - blood; California - epidemiology; Cardiovascular Diseases - blood; Cardiovascular Diseases - diagnosis; Cardiovascular Diseases - ethnology; cardiovascular epidemiology; diabetes; Diabetes Mellitus - blood; Diabetes Mellitus - diagnosis; Diabetes Mellitus - ethnology; Ethnicity; Female; Glycated Hemoglobin - metabolism; Humans; Male; Middle Aged; Original Research; race and ethnicity; Racial Groups; Retrospective Studies; Risk Assessment - methods; Risk Factors; California; cardiovascular epidemiology; diabetes; race and ethnicity
• ISSN: 2047-9980; 2047-9980
• DOI: 10.1161/JAHA.123.033559

Diabetes is the strongest risk factor for cardiovascular disease, and although glycosylated hemoglobin (HbA1c) levels are known to vary by race, no racial and ethnic-specific diagnostic thresholds exist for diabetes in prediction of cardiovascular disease events. The purpose of this study is to determine whether HbA1c thresholds for predicting major adverse cardiovascular events (MACEs) differ among racial and ethnic groups. This is a retrospective cohort study of Kaiser Permanente Northern California adult members (n=309 636) with no history of cardiovascular disease who had HbA1c values and race and ethnicity data available between 2014 and 2019. Multivariable logistic regression was used to evaluate the odds of MACEs by the following racial and ethnic groups: Filipino, South Asian, East Asian, Black, White, and Hispanic. A Youden index was used to calculate HbA1c thresholds for MACE prediction by each racial and ethnic group, stratified by sex. Among studied racial and ethnic groups, South Asian race was associated with the greatest odds of MACEs (1.641 [95% CI, 1.456-1.843]; <0.0001). HbA1c was a positive predictor for MACEs, with an odds ratio of 1.024 (95% CI, 1.022-1.025) for each 0.1% increment increase in HbA1c. HbA1c values varied between 6.0% and 7.6% in MACE prediction by race and ethnicity and sex. White individuals, South Asian individuals, East Asian women, and Black men had HbA1c thresholds for MACE prediction in the prediabetic range, between 6.0% and 6.2%. Black women, Hispanic men, and East Asian men had HbA1c thresholds of 6.2% to 6.6%, less than the typical threshold of 7.0% that is used as a treatment goal. Findings suggest that the use of race and ethnic- and sex-specific HbA1c thresholds may need to be considered in treatment goals and cardiovascular disease risk estimation.